Compounds > entinostat
Page last updated: 2024-10-31

entinostat and Squamous Cell Carcinoma of Head and Neck

entinostat has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Marques, AEM1
do Nascimento Filho, CHV1
Marinho Bezerra, TM1
Guerra, ENS1
Castilho, RM1
Squarize, CH1

Other Studies

1 other study available for entinostat and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Entinostat is a novel therapeutic agent to treat oral squamous cell carcinoma.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2020, Volume: 49, Issue:8

    Topics: Apoptosis; Benzamides; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; H

2020